-
Surprisingly! FDA Delays Approval of Eli Lilly's New Drug for Alzheimer's Disease
Surprisingly! US FDA Delays Approval of Eli Lilly's New Drug for Alzheimer's Disease: US pharmaceutical giant Eli Lilly announced on Friday that the US Food and Drug Administration (FDA) has unexpect ... -
Is Eli Lilly Alzheimer's medication about to be approved? Supported by FDA advisory panel, with a market value exceeding $800 billion for the first time
The Alzheimer's drug donanemab from pharmaceutical giant Eli Lilly is about to receive a green light from US regulatory agencies. The advisory committee of 11 independent experts convened by the US F ... -
Eisai/Bojian Alzheimer's disease drug rejected by the European Union, and Eli Lilly monoclonal antibody may be affected
New Beijing News (Reporter Zhang Zhaohui) Recently, the Medicines Committee of the European Medicines Agency stated that it does not recommend the marketing authorization application for the Alzheime ... -
Adding Alzheimer's disease testing for parents: 70% of Alzheimer's disease testing on Tmall will be ordered by children
How to tactfully ask parents to test for Alzheimer's disease? "Similar questions are not uncommon on Zhihu and Xiaohongshu. September 21st is World Alzheimer's Day. Despite the maturity of various me ... -
Lilly's Alzheimer's disease drug Kisunla approved for sale in the UK
According to Lilly, the Medicines and Medical Products Regulatory Authority (MHRA) in the UK has granted marketing authorization for its drug, donanemab, for Alzheimer's disease. Donanemab (trade nam ... -
Lilly's Alzheimer's disease drug Kisunla approved for sale in the UK
On October 26th, according to Eli Lilly, the Medicines and Medical Products Regulatory Authority (MHRA) in the UK has granted marketing authorization for its drug donanemab. Donanemab (trade name: Ki ...